38 Healthcare Stocks Moving In Monday's Pre-Market Session

Gainers

• Sol-Gel Technologies, Inc. SLGL shares moved upwards by 154.6% to $23.50 during Monday's pre-market session.
• Savara, Inc. SVRA stock rose 40.5% to $2.43.
• KemPharm, Inc. KMPH shares increased by 18.8% to $0.50. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.
• Cassava Sciences, Inc. SAVA stock moved upwards by 18.0% to $6.15.
• Capricor Therapeutics, Inc. CAPR stock rose 12.0% to $1.31.
• Guardion Health Sciences, Inc. GHSI shares surged 9.5% to $0.23.
• InVivo Therapeutics Hldg, Inc. NVIV shares increased by 8.9% to $0.20.
• Onconova Therapeutics, Inc. ONTX shares moved upwards by 8.7% to $0.45.
• Myriad Genetics, Inc. MYGN shares increased by 8.3% to $29.00.
• Genprex, Inc. GNPX shares rose 8.1% to $0.29.
• Brickell Biotech, Inc. BBI shares increased by 7.1% to $1.65.
• Avita Medical, Inc. RCEL shares moved upwards by 5.8% to $9.45.
• Check-Cap, Inc. CHEK stock moved upwards by 5.7% to $1.85.
• Bionano Genomics, Inc. BNGO stock moved upwards by 4.6% to $1.13.
• Titan Pharmaceuticals, Inc. TTNP shares surged 4.5% to $0.18. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
• Advaxis, Inc. ADXS shares increased by 4.3% to $0.85.
• Spring Bank, Inc. SBPH stock increased by 3.6% to $1.31. The most recent rating by B. Riley FBR, on December 30, is at Neutral, with a price target of $2.00.
• Marinus Pharmaceuticals, Inc. MRNS stock surged 3.5% to $2.35. The most recent rating by Oppenheimer, on December 20, is at Outperform, with a price target of $6.00.
• Solid Biosciences, Inc. SLDB stock moved upwards by 3.5% to $4.43. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.
• Ocugen, Inc. OCGN stock surged 3.5% to $0.41. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
• Viveve Medical, Inc. VIVE stock moved upwards by 3.4% to $0.93. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
• Durect, Inc. DRRX stock increased by 3.4% to $3.37. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.
• Axsome Therapeutics, Inc. AXSM shares moved upwards by 3.2% to $105.21. The most recent rating by Guggenheim, on December 16, is at Buy, with a price target of $158.00.
• Achieve Life Sciences, Inc. ACHV shares moved upwards by 2.8% to $0.55.
• Spectrum Pharmaceuticals, Inc. SPPI shares rose 2.3% to $3.62. The most recent rating by B. Riley FBR, on December 27, is at Buy, with a price target of $11.00.

Losers

• WAVE Life Sciences, Inc. WVE shares decreased by 32.6% to $10.65 during Monday's pre-market session. The most recent rating by SunTrust Robinson Humphrey, on December 17, is at Buy, with a price target of $27.00.
• ContraFect, Inc. CFRX stock fell 7.2% to $0.61.
• NewLink Genetics, Inc. NLNK stock decreased by 6.1% to $2.60.
• Iterum Therapeutics, Inc. ITRM stock fell 5.0% to $4.51. The most recent rating by RBC Capital, on December 11, is at Outperform, with a price target of $10.00.
• Mereo BioPharma Group, Inc. MREO shares declined 3.4% to $2.85.
• vTv Therapeutics, Inc. VTVT shares decreased by 3.4% to $1.73.
• Rite Aid, Inc. RAD shares declined 3.0% to $19.65.
• Assertio Therapeutics, Inc. ASRT shares plummeted 2.9% to $1.35.
• Agile Therapeutics, Inc. AGRX shares decreased by 2.9% to $2.36.
• Proteostasis Therapeutics, Inc. PTI shares fell 2.7% to $2.17.
• Aurora Cannabis, Inc. ACB shares declined 1.8% to $1.88. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
• Fresenius Medical Care, Inc. FMS shares decreased by 1.6% to $36.81. According to the most recent rating by Redburn, on October 23, the current rating is at Neutral.
• Biocept, Inc. BIOC stock plummeted 1.4% to $0.25.